- Home
- WAI vs CVKD Comparison
WAI vs CVKD Comparison
Compare WAI & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- CVKD
- Stock Information
- Founded
- WAI 2018
- CVKD 2022
- Country
- WAI China
- CVKD United States
- Employees
- WAI N/A
- CVKD N/A
- Industry
- WAI
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- WAI
- CVKD Health Care
- Exchange
- WAI NYSE
- CVKD Nasdaq
- Market Cap
- WAI 8.1M
- CVKD 29.5M
- IPO Year
- WAI 2023
- CVKD 2023
- Fundamental
- Price
- WAI $0.48
- CVKD $12.54
- Analyst Decision
- WAI
- CVKD Strong Buy
- Analyst Count
- WAI 0
- CVKD 1
- Target Price
- WAI N/A
- CVKD $32.00
- AVG Volume (30 Days)
- WAI 1.8M
- CVKD 36.2K
- Earning Date
- WAI 08-24-2025
- CVKD 08-06-2025
- Dividend Yield
- WAI N/A
- CVKD N/A
- EPS Growth
- WAI N/A
- CVKD N/A
- EPS
- WAI N/A
- CVKD N/A
- Revenue
- WAI $3,750,352.00
- CVKD N/A
- Revenue This Year
- WAI N/A
- CVKD N/A
- Revenue Next Year
- WAI N/A
- CVKD N/A
- P/E Ratio
- WAI N/A
- CVKD N/A
- Revenue Growth
- WAI N/A
- CVKD N/A
- 52 Week Low
- WAI $0.43
- CVKD $5.70
- 52 Week High
- WAI $20.00
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- CVKD 49.98
- Support Level
- WAI N/A
- CVKD $11.00
- Resistance Level
- WAI N/A
- CVKD $13.56
- Average True Range (ATR)
- WAI 0.00
- CVKD 1.15
- MACD
- WAI 0.00
- CVKD 0.25
- Stochastic Oscillator
- WAI 0.00
- CVKD 80.97
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.